Reduction of Sodium Valproate Compounds Concentrations in Water Intended for Human Consumption by Activated Carbon

The objective of our research project aimed at reducing sodium valproate was to reduce the concentration of this pharmaceutical compound.Their water holding capacity is achieved by a number of treatments and among these unique treatments are: advanced oxidation, bioproducts with biomass, adsorption and Catalytic oxidation is suitable for this type of waste.Drug metabolites were also found in wastewater and subsequently in surface water.Likewise, the heavy use of various drugs for humans and animals, leading to ineffective wastewater treatment, will lead to surface water pollution by these factors.Pharmaceuticals are generally synthetic organic classes used for the purpose of improving animal and human health.Excessive consumption of drugs as well as elimination of their metabolites through urine. Likewise, distribution without a prescription result in rare expiration of these substances; once expired, most end up in landfills.Internationally, studies have been conducted on the risks posed by excretion of pharmaceuticals in urine or directly into the trash, their metabolites being present in water usually intended for human consumption, some researchers say.Research has been conducted using many different means.to reduce their concentration in water intended for human consumption.In our research project, studies will be carried out on the laboratory installations and pilot installations of the water treatment laboratory of the Colentina laboratory complex, Faculty of Hydrotechnics.We take the example of the pharmaceutical substance sodium valproate as a pollutant by the adsorption treatment with granulate activated carbon at different concentrations (0.4, 0.8 and 1.6 mg/l) at two different flow rates (1.25 l/min and 2.5 l/min).